Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -26.45% is 78% above its 5-year average of -121.77%, near the high end of its 5-year range (-229.30%–-26.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 79.32% above its 12-month average of -127.88%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -17.51%.
RETURN ON ASSETS (ROA)
-26.45%
RETURN ON ASSETS (ROA) AVG TTM
-127.88%
RETURN ON ASSETS (ROA) AVG 3Y
-142.31%
RETURN ON ASSETS (ROA) AVG 5Y
-121.77%
RETURN ON ASSETS (ROA) AVG 10Y
-368.65%
RETURN ON ASSETS (ROA) AVG 15Y
-125.96%
RETURN ON ASSETS (ROA) AVG 20Y
-95.43%
CURRENT VS TTM AVG
+79.32%
CURRENT VS 3Y AVG
+81.41%
CURRENT VS 5Y AVG
+78.28%
CURRENT VS 10Y AVG
+92.83%
CURRENT VS 15Y AVG
+79.00%
CURRENT VS 20Y AVG
+72.28%
SECTOR MEDIAN · HEALTHCARE
-31.37%
median of 777 covered companies
CURRENT VS SECTOR MEDIAN
+15.68%
vs the sector median at left
Incannex Healthcare Limited
Market Cap
$37.93M
Return on Assets (ROA)
-26.45%
TTM Avg
-127.88%
3Y Avg
-142.31%
5Y Avg
-121.77%
Market Cap
$37.60M
Return on Assets (ROA)
-110.85%
TTM Avg
-107.44%
3Y Avg
-115.17%
5Y Avg
-101.88%
Market Cap
$37.18M
Return on Assets (ROA)
-120.78%
TTM Avg
-168.59%
3Y Avg
-147.82%
5Y Avg
-131.31%
Market Cap
$38.61M
Return on Assets (ROA)
-13.65%
TTM Avg
-40.30%
3Y Avg
-22.41%
5Y Avg
-15.81%
Market Cap
$36.28M
Return on Assets (ROA)
-60.08%
TTM Avg
-119.59%
3Y Avg
-67.97%
5Y Avg
-67.17%
Market Cap
$35.77M
Return on Assets (ROA)
-103.00%
TTM Avg
-39.81%
3Y Avg
-17.36%
5Y Avg
-12.69%
Market Cap
$39.84M
Return on Assets (ROA)
11.01%
TTM Avg
4.71%
3Y Avg
-17.75%
5Y Avg
-20.00%
Market Cap
$40.09M
Return on Assets (ROA)
-53.81%
TTM Avg
-31.90%
3Y Avg
-23.26%
5Y Avg
-21.62%
Market Cap
$40.22M
Return on Assets (ROA)
-40.69%
TTM Avg
-38.43%
3Y Avg
-19.21%
5Y Avg
-15.37%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.93M | -26.45% | -127.88% | -142.31% | -121.77% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.60M | -110.85% | -107.44% | -115.17% | -101.88% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $37.18M | -120.78% | -168.59% | -147.82% | -131.31% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | -13.65% | -40.30% | -22.41% | -15.81% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | -60.08% | -119.59% | -67.97% | -67.17% |
| DocGo Inc. (DCGO)vs › | $35.77M | -103.00% | -39.81% | -17.36% | -12.69% |
| Nephros, Inc. (NEPH)vs › | $39.84M | 11.01% | 4.71% | -17.75% | -20.00% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.09M | -53.81% | -31.90% | -23.26% | -21.62% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.22M | -40.69% | -38.43% | -19.21% | -15.37% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | -136.91% | -90.70% | -79.79% | -214.88% |
ROA
-26.4%
ROE
-28.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -26.45% |
| 2025-06-30 | -229.30% |
| 2024-06-30 | -108.28% |
| 2023-06-30 | -205.23% |
| 2022-06-30 | -39.20% |
| 2021-06-30 | -122.15% |
| 2020-06-30 | -110.41% |
| 2019-06-30 | -523.60% |
| 2018-06-30 | -413.35% |
| 2017-06-30 | -2068.42% |
| 2016-06-30 | -208.71% |
| 2015-06-30 | -40.63% |
| 2014-06-30 | -153.90% |
| 2013-06-30 | -69.65% |
| 2012-06-30 | -13.24% |
| 2011-06-30 | -23.00% |
| 2010-06-30 | 15.88% |
| 2009-06-30 | -26.41% |
| 2008-06-30 | -10.38% |
| 2007-06-30 | -14.41% |
| 2006-06-30 | -14.39% |
